The arrival of Retatrutide in the United Kingdom is creating significant excitement within the weight management community. This innovative dual agonist – targeting both GLP-1 and GIP – promises a significantly new strategy to tackling weight challenges. Until recently, options have been constrained for many, and Retatrutide signifies a hopeful